ConductScience.org, home

Paper40284397

Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone.

Borsodi MPG and 9 others. Pharmaceutics, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone. Papers, record 40284397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40284397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone.
PubMed
Journal
Pharmaceutics
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-04-28
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Borsodi MPGMaria Paula Gonçalveshttps://orcid.org/0000-0001-9440-5292
2Pacienza-Lima WWallace
3Menezes JCVJaqueline Correia Villaça
4Escrivani-Oliveira DDouglashttps://orcid.org/0000-0002-4872-8960
5Arruda-Costa NNatalia
6Silva AJMDAlcides José Monteiro da
7Cabral LMLucio Mendes
8Steel PGPatrick Ghttps://orcid.org/0000-0002-2493-5826
9Sousa-Batista AJAriane de Jesushttps://orcid.org/0000-0002-1642-6669
10Rossi-Bergmann BBartira

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
E-26/201.384/2022 (JCNE) and E26/010.002426/2019 (REDE SAÚDE)Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)PubMed

Source PubMed

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112615413Formulation of amphotericin B as nanosuspension for oral administration.Int J Pharm2003https://conductscience.org/library/papers/12615413PubMed
223383426Strategies to address low drug solubility in discovery and development.Pharmacol Rev2013https://conductscience.org/library/papers/23383426PubMed
338543222Design Space and Control Strategy for the Manufacturing of Wet Media Milled Drug Nanocrystal Suspensions by Adopting Mechanistic Process Modeling.Pharmaceutics2024https://conductscience.org/library/papers/38543222PubMed
425860834pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.J Med Chem2015https://conductscience.org/library/papers/25860834PubMed
510223942Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10223942PubMed
639608687Brominated chalcones as promising antileishmanial agents.Bioorg Med Chem Lett2025https://conductscience.org/library/papers/39608687PubMed
726998867Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability.Colloids Surf B Biointerfaces2016https://conductscience.org/library/papers/26998867PubMed
823985066Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.Parasitology2014https://conductscience.org/library/papers/23985066PubMed
929263064Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29263064PubMed
1028668673The chemotherapeutic potential of chalcones against leishmaniases: a review.Int J Antimicrob Agents2018https://conductscience.org/library/papers/28668673PubMed
1123415952In vitro and in vivo models for the study of oral delivery of nanoparticles.Adv Drug Deliv Rev2013https://conductscience.org/library/papers/23415952PubMed
1216386424Synthesis of chalcone analogues with increased antileishmanial activity.Bioorg Med Chem2006https://conductscience.org/library/papers/16386424PubMed
1332364107Single-dose treatment for cutaneous leishmaniasis with an easily synthesized chalcone entrapped in polymeric microparticles.Parasitology2020https://conductscience.org/library/papers/32364107PubMed
1431766540Formation of Prenylated Chalcone Xanthohumol Cocrystals: Single Crystal X-Ray Diffraction, Vibrational Spectroscopic Study Coupled with Multivariate Analysis.Molecules2019https://conductscience.org/library/papers/31766540PubMed
1525455766Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.Int J Pharm2014https://conductscience.org/library/papers/25455766PubMed
1623224077Reactivity assessment of chalcones by a kinetic thiol assay.Org Biomol Chem2013https://conductscience.org/library/papers/23224077PubMed
1734780470Chalcones identify cTXNPx as a potential antileishmanial drug target.PLoS Negl Trop Dis2021https://conductscience.org/library/papers/34780470PubMed
1829326082Pharmaceutical nanocrystals: production by wet milling and applications.Drug Discov Today2018https://conductscience.org/library/papers/29326082PubMed
1928732905Preparation of fungus-derived chitin nanocrystals and their dispersion stability evaluation in aqueous media.Carbohydr Polym2017https://conductscience.org/library/papers/28732905PubMed
2022355202Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein.Korean J Parasitol2011https://conductscience.org/library/papers/22355202PubMed

See all 34 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40284397

GET https://conductscience.org/api/papers/v1/40284397/references?page=2